• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
      • Creating value for start-ups
      • The IP driven start-up
    • Financial Services
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • Unified Patent Court hub
    • Beyond Brexit: European trade mark hub
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
    • Creating value for start-ups
    • The IP driven start-up
  • Financial Services
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • Unified Patent Court hub
  • Beyond Brexit: European trade mark hub
  • M&C Reacts
Photo: Bruce Dowsing

Bruce Dowsing

Senior Associate

Asia
Singapore

Get in contact

+65 6227 8986 bdowsing@marks-clerk.com.sg
vCard

Bruce is a Singapore Registered Patent Attorney, Australian and New Zealand Registered Patent Attorney. A Singapore-based patent attorney, Bruce has drafted and prosecuted local and foreign patent applications relating to molecular and cell biology, such as stem cells, antibodies, fusion proteins, pharmaceuticals, nutraceuticals, transgenic plants, medical diagnostics, and is one of the few to file and prosecute an application for plant variety protection in Singapore. Bruce provides advice in relation to patentability and patent infringement. He has experience in IP due diligence and contentious matters including patent opposition proceedings (in Australia).

Bruce holds a BSc (Hons) in Biochemistry and Microbiology, from Monash University and a PhD in the field of neuroscience from the University of Sydney. Bruce spent 10 years in postdoctoral research; at the University of Melbourne characterising neuronal cell adhesion molecules and at The Bernard O’Brien Institute of Microsurgery, St. Vincent’s Hospital, Melbourne, testing the effects of cytokines in animal models of peripheral nerve injury and repair.

Bruce entered the patent profession in 2001, and practised with a leading Australian firm before moving to Singapore in 2014 to join Marks & Clerk.
 

Languages

  • English

Specialist in

  • Patents
  • Chemistry
  • Food and drink
  • Medical technologies
  • Life Sciences

Qualifications

BSc, PhD

Search our people

Latest Insights

Hermes birkin
Article
- 31 January 2023

The MetaBirkin and the very modern debate unfolding in Hermès International, et al v. Mason Rothschild

A boundary testing trade mark case continues in the US between Hermès International and Mason Rothschild and we eagerly await the outcome.  This case is likely to set a precedent about how trade mark rights can extend to, and be enforced in, the virtual space / metaverse.
Read more
Article
- 26 January 2023

New year, new scale of costs: UKIPO publishes practice note TPN 1/2023

Earlier this week, the IPO brought together updated the guidance from previous TPNs about costs in trade mark, patent and design tribunal proceedings in (TPN) 1/2023.
Read more
News
- 26 January 2023

Return to sender, address unknown

Hot off the press is the long awaited guidance from the UKIPO on service of documents in contentious proceedings upon parties who do not have a UK address for service.  
Read more
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Lexology
  • Mondaq